Key Points

Bhaskar Chakravorti from Tufts University suggests Trump's recent pharmaceutical tariffs won't immediately harm Indian manufacturers. The expert believes ongoing negotiations between India and the US are crucial for maintaining economic ties. While current tariffs target patented drugs, he warns generic pharmaceuticals could be impacted in the future. Chakravorti recommends India develop a strategic approach to manage relations with the Trump administration.

Key Points: Trump Pharma Tariffs Unlikely to Hit India Now

  • Trump's 100% pharma tariffs currently exempt Indian manufacturers
  • India negotiating for tariff rates below 20%
  • Bilateral trade talks continue amid visa and economic tensions
  • Potential future generic pharmaceutical tariffs possible
4 min read

Trump's pharma tariffs won't impact India for now, says expert (IANS Exclusive)

Expert Bhaskar Chakravorti reveals Trump's pharmaceutical tariffs won't immediately impact India, warns of potential future restrictions

"This specific move to put tariffs on patented pharmaceuticals is not something that is directly going to affect the Indian manufacturers - Bhaskar Chakravorti"

Washington, Sep 27

Bhaskar Chakravorti, the Dean of Global Business at The Fletcher School of Law and Diplomacy at Tufts University, said that Trump's decision to impose 100 per cent tariffs on pharmaceuticals won't impact India, at least for now.

In an exclusive interview with IANS on Friday, Chakravorti argued that he wouldn't "rule out" tariffs on Indian generic pharmaceuticals in future.

"This specific move to put tariffs on patented pharmaceuticals is not something that is directly going to affect the Indian manufacturers as much, but it's coming awfully close. So, I wouldn't rule it out that somewhere down the road, tariffs on generic pharmaceuticals as well," he added.

US President Donald Trump announced on Thursday that any patented or branded pharmaceutical products will be subject to a 100 per cent tariff starting October 1, unless the company is building a manufacturing plant in the US.

Commenting on the ongoing negotiations between India and the United States amid the recent crackdown on H-1B visas, Chakravorti believed that "it does make a lot of sense to continue negotiations" on trade issues as well as on the visa changes.

"There is mutual benefit in continuing to have these conversations and find a peaceful settlement to the impasse, particularly the tariff impasse. The H-1B issue is related, but it's a separate issue. I think the two need to be negotiated in parallel, as opposed to in one place," he noted.

Sources have told IANS that New Delhi is pressing for a tariff rate below 20 per cent in its ongoing negotiations with the United States.

The push for tariffs below 20 per cent is viewed as vital to safeguarding India's competitiveness, given that other South and Southeast Asian nations face US tariff rates between 15-20 per cent.

Sources added that New Delhi is also pressing for the removal of the additional 25 per cent tariff on Russian oil purchases, aligning with the Trump administration's view that European nations should curb their imports as well and reiterating that India should not be singled out.

However, Chakravorti, who is a former McKinsey & Company Partner, advised that India should seriously consider reducing its purchase of Russian oil, which would be its "biggest signal" to the Trump administration.

"Any move that India makes in terms of reducing its purchase of oil from Russia is probably going to be the biggest signal from any major country in acting on a set of choices that Trump has made. India can legitimately make the point that this is not economically feasible for India, and it's contributing to Trump's claim that he is effectively campaigning for and bringing peace. That is an offer that India can make," he emphasised.

External Affairs Minister (EAM) S Jaishankar met US Secretary of State Marco Rubio on Monday on the sidelines of UN General Assembly meetings. Commerce and Industry Minister Piyush Goyal and US Trade Representative Jamieson Greer also held discussions in New York, which the Indian side termed as "constructive meetings"

"Both sides exchanged views on possible contours of the deal and it was decided to continue the engagements with a view to achieve early conclusion of a mutually beneficial Trade Agreement," the Commerce Ministry statement added.

Chakravorti acknowledged that Trump's current economic policies are hurting the US economy, but for the other countries, there is no substitute for the American market in the near term.

"The US economy is already suffering, and it's going to continue to suffer, and the consumer demand is going to be hit. So, you need to look for alternative markets. Give me an alternative. You can put together 50 markets and still it doesn't come close to covering the deficit," he asserted.

For both the near and long term, Chakravorti believed India should strive for a better relationship with the United States.

"The biggest problem right now is Trump. But to some extent, Trump is also transparent in terms of what gets him upset and what makes him happy and how you can get him to come to your side. If you start with that as a motivation, you then need to develop a strategy around. That's the kind of thing that India needs to do in the near term and over the longer term, India needs to have a campaign to build back that relationship, which, in the moment seems to be broken," he concluded.

- IANS

Share this article:

Reader Comments

R
Rohit P
Why should India reduce Russian oil purchases just to please Trump? We have our own economic interests. The expert's suggestion seems biased towards US perspective. India should prioritize affordable energy for our growth.
M
Michael C
As someone working in pharma exports, this is concerning. While generics are safe today, the uncertainty affects our long-term planning. Hope the trade negotiations bring stability soon.
A
Ananya R
The H-1B visa issue is really worrying for IT professionals. Glad they're discussing it along with trade. Many families' futures depend on these negotiations. Hope for a positive outcome! 🤞
S
Sarah B
Interesting perspective. India needs to play smart diplomacy here. While maintaining relations with US is important, we shouldn't compromise on our strategic autonomy. The 20% tariff negotiation seems reasonable.
V
Vikram M
The expert is right about needing alternative markets. We should focus more on EU, African and Latin American markets. Over-dependence on any single market is risky for our economy.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50